Search for: "Nicholson Price"
Results 101 - 120
of 154
Sorted by Relevance
|
Sort by Date
9 Apr 2021, 8:03 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
How is regulatory policy influencing the development and marketing of antibody testing for COVID-19?
4 May 2020, 12:56 pm
By Nicholson Price, Rachel Sachs, Jacob Sherkow, and Lisa Larrimore OuelletteOver the last few weeks, dozens of companies have begun marketing tests intended to determine whether someone has antibodies directed to SARS-CoV-2, the virus that causes COVID-19. [read post]
3 Mar 2022, 6:43 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
2 Jul 2020, 10:15 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
6 Dec 2021, 6:24 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
12 Oct 2020, 11:52 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsA recent STAT News report found that Operation Warp Speed—the government’s Manhattan Project-style effort to quickly develop a COVID-19 vaccine—has substantial military involvement. [read post]
3 Feb 2023, 7:23 am
Nicholson Price: Utility patent imperialism: why aren’t they patents if they say patents on them. [read post]
30 Oct 2020, 12:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
27 Apr 2020, 1:27 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide are facing shortages of crucial medical supplies, including personal protective equipment (PPE), diagnostic testing components including kits and nasal swabs, and even ventilators or ventilator parts. [read post]
18 Dec 2020, 6:37 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsThe past two weeks have been full of exciting COVID-19 vaccine news, including the FDA’s emergency use authorizations (EUAs) for the Pfizer–BioNTech and Moderna vaccines and the nationwide rollout of Pfizer’s vaccine. [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
18 Mar 2023, 8:08 am
Pallavi Bugga and Nicholson Price rightly contend that human-AI interactions are hard to model and to regulate, but we have no choice at this point but to research and translate what we know about human-machine interactions into better policy. [read post]
18 Jun 2020, 1:23 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsIn the United States, one of the most important factors in receiving COVID-19 testing or treatment is access to insurance. [read post]
27 Sep 2021, 7:26 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsHistorically, the United States’ preparedness for a pandemic is like Charles Dudley Warner’s aphorism on the weather: everybody talks about it but no one ever does anything. [read post]
19 Feb 2016, 10:12 am
But, traditional answer: higher prices mean higher deadweight losses and higher transaction costs to be balanced against marginal benefits. [read post]
23 Aug 2012, 3:53 pm
References: Trainor Fairbrook, Cox, Castle & Nicholson, Pillsbury Winthrop Shaw Pittman, and Porter Law Group. [read post]
24 Jun 2009, 1:22 pm
Claire: Poussin, Ben Nicholson, Durer, Ken Price, and the fabulous Steffen Dam. [read post]
8 Nov 2010, 4:36 pm
No matter… Ben’s quantitative easing has no shot at fixing either of those things, housing prices or jobs, so woohoo! [read post]
10 Dec 2010, 1:09 pm
Nicholson, Ph.D. [read post]
13 Jul 2010, 3:03 pm
And even if you look at it as an over-priced lottery ticket, it still beats the alternative. [read post]
